Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 14, 2026, 4:08 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 721–744 of 1,098 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Physiological Clear all

Conditions: Sexual Dysfunction, Physiological
Interventions: Testosterone Cream, Estring; Drug
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years to 80 Years · Female only
Enrollment: 76 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2012
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Obesity, Body Weight
Interventions: DGA Mediterranean diet pattern, energy balance, DGA Mediterranean diet pattern, negative energy balance, TAD diet pattern, negative energy balance; Other
Lead sponsor: USDA, Western Human Nutrition Research Center; Federal
Eligibility: 19 Years to 64 Years · Female only
Enrollment: 54 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Davis, California

Conditions: Sexual Dysfunction
Interventions: Abilify Maintena; Drug
Lead sponsor: Gazda, Thomas D., M.D., PC; Individual
Eligibility: 18 Years to 40 Years
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Bullhead City, Arizona

Conditions: Coronary Artery Disease
Interventions: iFR, FFR; Device
Lead sponsor: Imperial College London; Other
Eligibility: 18 Years to 90 Years
Enrollment: 2,500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2021
U.S. locations: 6
States / cities: Long Beach, California • Lakewood, Colorado • Atlanta, Georgia + 3 more

Conditions: Obesity, Overweight
Interventions: LY3437943, Placebo; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 338 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 25
States / cities: Scottsdale, Arizona • Anaheim, California • Fresno, California + 21 more

Conditions: Peripheral Artery Disease (PAD)
Interventions: Ticagrelor, Comparator; Drug
Lead sponsor: AstraZeneca; Industry
Eligibility: 50 Years to 130 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 10
States / cities: Daytona Beach, Florida • Jacksonville, Florida • Ocala, Florida + 7 more

Conditions: Craving, Self Efficacy, Affective; Reaction, Substance Abuse
Interventions: CARESS, Isometric Exercise; Behavioral
Lead sponsor: Inova Health Care Services; Other
Eligibility: 18 Years and older
Enrollment: 96 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Fairfax, Virginia

Conditions: Premature Ejaculation
Interventions: Placebo, Promescent Lidocaine Spray; Drug
Lead sponsor: Eugene Y Rhee, MD; Other
Eligibility: 18 Years and older · Male only
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 2
States / cities: Los Angeles, California • San Diego, California

Conditions: Gynaecologic Cancer
Interventions: Nurse Led Sexual Health Clinical Program Intervention; Other
Lead sponsor: Cedars-Sinai Medical Center; Other
Eligibility: 30 Years to 65 Years · Female only
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Virus Diseases, RNA Virus Infections, Respiratory Tract Diseases, Respiratory Tract Infections
Interventions: 30 µg/strain of Quadrivalent VLP Vaccine, 60 µg/strain of Quadrivalent VLP Vaccine, FluLaval® Tetra (15 µg/strain), Fluzone® High-Dose (60 µg/strain); Biological
Lead sponsor: Medicago; Industry
Eligibility: 65 Years and older
Enrollment: 1,001 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2017
U.S. locations: 6
States / cities: Redding, California • Hollywood, Florida • South Miami, Florida + 3 more

Conditions: Cardiovascular Diseases, Natriuretic Peptides, Cardiometabolic Diseases, Energy Expenditure, Glucose Metabolism, Exercise, Obesity
Interventions: Study diet, Exercise capacity VO2 max determination, Exercise Challenge, Glucose Challenge; Dietary Supplement · Other
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Erectile Dysfunction (ED)
Interventions: Rigicon Infla10® Inflatable Penile Prosthesis (IPP); Device
Lead sponsor: Rigicon, Inc.; Industry
Eligibility: 22 Years and older · Male only
Enrollment: 182 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 4
States / cities: Coral Gables, Florida • Tampa, Florida • Atlanta, Georgia + 1 more

Conditions: PTSD - Post Traumatic Stress Disorder
Interventions: Written Exposure Therapy (WET), methylphenidate (MPH), placebo (PBO); Behavioral · Drug
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years to 65 Years
Enrollment: 138 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2030
U.S. locations: 1
States / cities: San Diego, California

Conditions: Erectile Dysfunction
Interventions: Udenafil, Placebo; Drug
Lead sponsor: Warner Chilcott; Industry
Eligibility: 19 Years and older · Male only
Enrollment: 618 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 36
States / cities: Birmingham, Alabama • Homewood, Alabama • Mesa, Arizona + 32 more

Conditions: Breast Cancer
Interventions: vitamin D3; Drug
Lead sponsor: Carol Fabian, MD; Other
Eligibility: Up to 55 Years · Female only
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: Kansas City, Kansas

Conditions: Atrial Fibrillation (AF)
Interventions: Bachmann's Bundle Pacing, Right Atrial Appendage Pacing; Device
Lead sponsor: Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute); Other
Eligibility: 18 Years and older
Enrollment: 334 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Atropine Bioequivalence
Interventions: Atropine Sulfate Ophthalmic Solution USP, 1%, Atropine Sulfate Injection, USP 8 mg/20 mL (0.4 mg/mL); Drug
Lead sponsor: Biomedical Advanced Research and Development Authority; Federal
Eligibility: 18 Years to 65 Years
Enrollment: 46 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024
U.S. locations: 1
States / cities: Lenexa, Kansas

Conditions: Cardiac Output, Low, Stroke Volume
Interventions: Vitalstream; Device
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older
Enrollment: 58 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Schizophrenia
Interventions: Dronabinol, Placebo Comparator; Drug · Other
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years to 50 Years
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2011
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Erectile Dysfunction
Interventions: ASP-001.1, ASP-001.1; Drug · Device
Lead sponsor: Aspargo Labs, Inc; Industry
Eligibility: 20 Years to 70 Years · Male only
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: New York, New York

Conditions: Arthralgia, Breast Cancer, Hot Flashes, Musculoskeletal Complications, Sexual Dysfunction
Interventions: testosterone, placebo; Drug · Other
Lead sponsor: Alliance for Clinical Trials in Oncology; Other
Eligibility: 18 Years and older · Female only
Enrollment: 227 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2019
U.S. locations: 528
States / cities: Anchorage, Alaska • Hot Springs, Arkansas • Auburn, California + 331 more

Conditions: Weight Loss, Reflux
Interventions: Metabolic and Hormonal profile; Other
Lead sponsor: Northwell Health; Other
Eligibility: 18 Years to 75 Years
Enrollment: 4 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: New York, New York

Conditions: Major Depressive Disorder
Interventions: LY03005; Drug
Lead sponsor: Luye Pharma Group Ltd.; Industry
Eligibility: 18 Years to 50 Years
Enrollment: 34 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Obstetric; Injury Pelvic Floor, Sexual Dysfunction, Anal Incontinence, Urinary Incontinence
Interventions: Estradiol 0.01% Vag Cream, Placebo vaginal cream; Drug
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years and older · Female only
Enrollment: 38 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Birmingham, Alabama

Search by objective public record fields.

Vaginal Testosterone Cream vs ESTRING for Vaginal Dryness or Decreased Libido in Early Stage Breast Cancer Patients

Metabolic and Bio-behavioral Effects of Following Recommendations in the Dietary Guidelines for Americans

Aripiprazole, Abilify Maintena Collaborative Clinical Protocol

Functional Lesion Assessment of Intermediate Stenosis to Guide Revascularisation

A Study of LY3437943 in Participants Who Have Obesity or Are Overweight

Walking Effect of Long Term Ticagrelor in Subjects With PAD Who Have Undergone EVR

CARESS: An Investigation of Effects of CARESS

Efficacy of Promescent Lidocaine Spray in Men With Premature Ejaculation

Improving Sexual Health in Gynecological Cancer Patients

Immunogenicity, Safety, and Tolerability of a Plant-Derived Quadrivalent VLP Influenza Vaccine in Elderly Adults

GENESIS: Genotype Guided - Natriuretic Peptides - Cardiometabolic Health Study

Evaluation of the Rigicon Infla10® Inflatable Penile Prosthesis (IPP) for Erectile Dysfunction

Written Exposure Therapy Plus Adjunctive Methylphenidate Treatment for Veterans With PTSD

Treatment of Erectile Dysfunction I

Modulation of Breast Cancer Risk Biomarkers by High Dose Vitamin D

Bachmann's Bundle Versus Right Atrial Appendage Pacing

Sublingual Atropine Bioequivalence by Route of Administration (SABER)

Perioperative Monitoring of Cardiac Surgery Patients With the Vitalstream Physiological Monitor

The Effects of Cannabis Use in People With Schizophrenia on Clinical, Neuropsychological and Physiological Phenotypes

The Objective of This Phase 1 Study is to Evaluate the Food Effect of 100 mg Hezkue Turbo® (ASP-001.1, Sildenafil) Under Fed Versus 100 mg of Hezkue Turbo® (ASP-001.1, Sildenafil) Under Fasted Conditions in Healthy Adult Male Subjects

Testosterone in Treating Postmenopausal Patients With Arthralgia Caused by Adjuvant Aromatase Inhibitor Treatment

Mechanism of Weight Loss After Endoscopic and Laparoscopic Sleeve Procedures

A Relative Bioavailability Food Effect Study of LY03005

Topical Vaginal Estrogen for Postpartum Obstetric Anal Sphincter Injury Recovery